Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

UBS Called Novo Nordisk a 'Value Trap.' Here's the Other Side of That Argument.

UBS analyst Michael Yee called Novo Nordisk a value trap, but still sees a turnaround playing out over time.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at fool.com →

More in Finance & Markets

More from Friday 9 October →